Changes in retinoblastoma gene expression during cervical cancer progression
- 1 December 2002
- journal article
- research article
- Published by Wiley in International Journal of Experimental Pathology
- Vol. 83 (6) , 275-286
- https://doi.org/10.1046/j.1365-2613.2002.00198.x
Abstract
Summary. The role of tumour suppressor genes in the development of human cancers has been studied extensively. In viral carcinogenesis, the inactivation of suppressor proteins such as retinoblastoma (pRb) and p53, and cellular oncogenes overexpression, such as c‐myc, has been the subject of a number of investigations. In uterine‐cervix carcinomas, where high‐risk human papillomavirus (HPV) plays an important role, pRb and p53 are inactivated by E7 and E6 viral oncoproteins, respectively. However, little is known about the in situ expression of some of these proteins in pre‐malignant and malignant cervical tissues. On the other hand, it has also been demonstrated that c‐myc is involved in cervical carcinogenesis, and that pRb participates in the control of c‐myc gene expression. By using immunostaining techniques, we investigated pRb immunodetection pattern in normal tissues, squamous intraepithelial lesions (SILs) and invasive carcinomas from the uterine cervix. Our data show low pRb detection in both normal cervical tissue and invasive lesions, but a higher expression in SILs. C‐Myc protein was observed in most of the cellular nuclei of the invasive lesions, while in SILs was low. These findings indicate a heterogeneous pRb immunostaining during the different stages of cervical carcinogenesis, and suggest that this staining pattern could be a common feature implicated in the pathogenesis of uterine‐cervix carcinoma.Keywords
This publication has 55 references indexed in Scilit:
- Molecular Characterization of Adenocarcinoma of the CervixGynecologic Oncology, 1997
- Translocation of the Retinoblastoma Gene Product during MitosisExperimental Cell Research, 1996
- Aberrant RB gene expression in routinely processed, archival tumor tissues determined by three different anti‐RB antibodiesInternational Journal of Cancer, 1994
- Altered Expression of the Retinoblastoma Gene Product: Prognostic Indicator in Bladder CancerJNCI Journal of the National Cancer Institute, 1992
- The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated mannerCell, 1992
- Viruses in Human CancersScience, 1991
- Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene productNature, 1991
- Detection and Typing of Multiple Genital Human Papillomaviruses by DNA Amplification with Consensus PrimersJapanese Journal of Cancer Research, 1991
- Expression of RB and p53 proteins in HPV‐positive and HPV‐negative cervical carcinoma cell linesMolecular Carcinogenesis, 1991
- The Human Papilloma Virus-16 E7 Oncoprotein Is Able to Bind to the Retinoblastoma Gene ProductScience, 1989